Urgent.News

What's breaking now, across hundreds of outlets.

Culture

Bayer Roundup Settlement: Who Qualifies and How Much Could They Get?

Awards may reach $165,000, but age, diagnosis and exposure history will help determine how much each qualifying claimant receives.

A Missouri judge approved Bayer's $7.25 billion settlement of lawsuits claiming its Roundup weedkiller causes cancer. The June U.S. Supreme Court ruling made it harder to sue Monsanto, which owns Roundup, over the lack of a cancer warning on the product. Eligible claimants must have been diagnosed with non-Hodgkin lymphoma or receive a diagnosis within the program's 16-year coverage period, starting February 17, 2026.

Timothy Boyer, the judge, deemed the agreement "fair, reasonable, and adequate." Monsanto denies liability and insists that glyphosate does not cause cancer. The settlement cover U.S. residents exposed to Roundup before the cutoff date, who developed non-Hodgkin lymphoma or receive a diagnosis during the program. Compensation depends on the type of exposure (occupational or residential) and various factors, including age, disease aggressiveness, and quality of exposure evidence.

Eligible claimants must provide medical records, exposure proof, identification, and residency evidence. The administrator, BrownGreer PLC, will process claims through a secure portal. The settlement does not provide a direct path for those who previously settled with Monsanto, as some prior agreements may affect payout calculations.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at newsweek.com →

Report a problem with this story

More in Culture

More from Saturday 21 November →